Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF
AssigneeThomas Jefferson University
InventorsMichael J. Mastrangelo, Edmund C. Lattime, David Berd, Laurence C. Eisenlohr
Life of this patent
Estimating the term…
Abstract
A method of inducing expression of immune active cytokines in tumors in situ is provided wherein a vaccinia virus vector capable of inducing expression of a selected cytokine is generated and injected into a tumor so that cells of the tumor express the selected cytokine. A method of enhancing immunity in a host by administration of a vaccinia virus vector is also provided. Methods of treating cancer by administration of these vaccinia virus vectors are also provided.
Claims4
A method of expressing granulocyte-macrophage colony stimulating factor in tumors in situ comprising:
- a) generating a vaccinia virus vector encoding a gene for granulocyte-macrophage colony stimulating factor operably linked to transcriptional regulatory elements;
- and b) injecting said vaccinia virus into a tumor so that cells of the tumor express granulocyte-macrophage colony stimulating factor.
A method of producing regression of a tumor in a mammal having cancer comprising administering to the tumor in said mammal a vaccinia virus vector encoding a gene for granulocyte-macrophage colony stimulating factor operably linked to transcriptional regulatory elements in an amount capable of inducing an immune response to the tumor in the mammal such that the tumor regresses.
Dependencies are inferred from the claim text.